Venturi Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Venturi Wealth Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,259	Closed	-$124K	–	2072
2024 Q3	$124K	Buy	1,259 +1,248	+11,345%	+$123K	0.01%	516
2024 Q2	$1.02K	Sell	11 -2,000	-99%	-$179K	﹤0.01%	1485
2024 Q1	$191K	Buy	+2,011	New	+$187K	0.01%	351
2023 Q4	–	Sell	-7,233	Closed	-$528K	–	1445
2023 Q3	$528K	Buy	+7,233	New	+$578K	0.04%	236
2023 Q2	–	Sell	-4,780	Closed	-$364K	–	1290
2023 Q1	$364K	Buy	+4,780	New	+$397K	0.03%	255

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Venturi Wealth Management's XBI Position: Q4 2024 in Review

Venturi Wealth Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2024, closing a stake of 1,259 shares — an estimated $124K sold.

Venturi Wealth Management first reported a position in XBI in Q1 2023 and held it in 5 quarters. The position peaked at $528K in Q3 2023. 738 funds tracked by Wall St. Rank hold XBI as of Q4 2024.

Venturi Wealth Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2024 after selling out during the quarter.
Venturi Wealth Management sold 1,259 State Street SPDR S&P Biotech ETF shares in Q4 2024, an estimated $124K.
Venturi Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2023 and held it in 5 quarters.
Venturi Wealth Management's State Street SPDR S&P Biotech ETF position peaked at $528K in Q3 2023.
738 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2024.

Based on Venturi Wealth Management's 13F filing for Q4 2024, filed 31 Jan 2025.